Total Payments
$970.77
2024 Payments
$100.28
Companies
13
Transactions
24
Medicare Patients
882
Medicare Billing
$107,293
Payment Breakdown by Category
Food & Beverage$930.77 (95.9%)
Consulting$40.00 (4.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $930.77 | 23 | 95.9% |
| Consulting Fee | $40.00 | 1 | 4.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $342.13 | 4 | $0 (2020) |
| Medtronic, Inc. | $100.28 | 1 | $0 (2024) |
| AbbVie Inc. | $94.23 | 2 | $0 (2021) |
| Astellas Pharma US Inc | $83.46 | 4 | $0 (2020) |
| Cardiovascular Systems Inc. | $76.05 | 1 | $0 (2017) |
| AngioDynamics, Inc. | $55.14 | 1 | $0 (2019) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $53.72 | 3 | $0 (2023) |
| The Medicines Company | $45.08 | 3 | $0 (2017) |
| bioMerieux Inc | $40.00 | 1 | $0 (2023) |
| Insmed, Inc. | $24.77 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $100.28 | 1 | Medtronic, Inc. ($100.28) |
| 2023 | $63.17 | 2 | bioMerieux Inc ($40.00) |
| 2022 | $24.77 | 1 | Insmed, Inc. ($24.77) |
| 2021 | $94.23 | 2 | AbbVie Inc. ($94.23) |
| 2020 | $198.13 | 5 | Allergan, Inc. ($160.50) |
| 2019 | $300.63 | 5 | Allergan Inc. ($181.63) |
| 2018 | $45.10 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($30.55) |
| 2017 | $144.46 | 5 | Cardiovascular Systems Inc. ($76.05) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/16/2024 | Medtronic, Inc. | INTERSTIM (Device) | Food and Beverage | In-kind items and services | $100.28 | General |
| Category: Sacral Nerve Stimulation | ||||||
| 03/27/2023 | bioMerieux Inc | BIOFIRE RESPIRATORY PANEL 2.1 (Device) | Consulting Fee | Cash or cash equivalent | $40.00 | General |
| Category: Diagnostics | ||||||
| 03/24/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $23.17 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/17/2022 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $24.77 | General |
| Category: Respiratory | ||||||
| 05/20/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $75.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/24/2021 | AbbVie Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/17/2020 | Allergan, Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/22/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: ANTI-INFECTIVE | ||||||
| 03/11/2020 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 03/09/2020 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 02/11/2020 | Allergan, Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/13/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/03/2019 | Allergan Inc. | AVYCAZ (Drug) | Food and Beverage | In-kind items and services | $181.63 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/25/2019 | Merck Sharp & Dohme Corporation | DIFICID (Drug), ZINPLAVA | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/24/2019 | AngioDynamics, Inc. | — | Food and Beverage | In-kind items and services | $55.14 | General |
| Category: VIT | ||||||
| 05/16/2019 | Astellas Pharma US Inc | CRESEMBA (Drug) | Food and Beverage | In-kind items and services | $22.69 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/17/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $19.14 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/07/2018 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.41 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/26/2018 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiology | ||||||
| 12/12/2017 | The Medicines Company | VABOMERE (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/13/2017 | Cardiovascular Systems Inc. | Peripheral Orbital Atherectomy System (Device) | Food and Beverage | Cash or cash equivalent | $76.05 | General |
| Category: Atherectomy Device | ||||||
| 08/09/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 04/12/2017 | The Medicines Company | ORBACTIV (Drug) | Food and Beverage | In-kind items and services | $10.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/07/2017 | ViiV Healthcare Company | TRIUMEQ (Drug), TIVICAY | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 165 | 256 | $60,708 | $19,800 |
| 2022 | 6 | 242 | 414 | $85,588 | $31,916 |
| 2021 | 7 | 271 | 441 | $74,382 | $31,715 |
| 2020 | 5 | 204 | 338 | $57,154 | $23,863 |
Total Patients
882
Total Services
1,449
Medicare Billing
$107,293
Procedure Codes
26
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 56 | 114 | $21,120 | $6,803 | 32.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 35 | 38 | $13,715 | $3,835 | 28.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 17 | 29 | $9,020 | $2,518 | 27.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 16 | $6,224 | $2,196 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 21 | 29 | $3,079 | $1,936 | 62.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 12 | $6,190 | $1,620 | 26.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 14 | 18 | $1,359 | $891.99 | 65.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 75 | 212 | $34,207 | $11,617 | 34.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 60 | 66 | $29,493 | $10,264 | 34.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 31 | 44 | $4,492 | $3,211 | 71.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 25 | 34 | $7,952 | $2,752 | 34.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 22 | $6,933 | $2,276 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 29 | 36 | $2,511 | $1,796 | 71.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 103 | 237 | $31,989 | $12,880 | 40.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 43 | 46 | $17,529 | $6,868 | 39.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 28 | 38 | $7,410 | $2,965 | 40.0% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 32 | 34 | $6,564 | $2,676 | 40.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 19 | 21 | $5,429 | $2,309 | 42.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 16 | 24 | $2,583 | $1,842 | 71.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 15 | 21 | $1,471 | $1,091 | 74.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 15 | 20 | $1,407 | $1,085 | 77.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 101 | 223 | $29,668 | $12,359 | 41.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 44 | 47 | $17,589 | $7,135 | 40.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 27 | 27 | $6,863 | $2,964 | 43.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 12 | 12 | $2,284 | $974.43 | 42.7% |
About Dr. Addie Spier, M.D
Dr. Addie Spier, M.D is a Infectious Disease healthcare provider based in Columbia, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/05/2009. The National Provider Identifier (NPI) number assigned to this provider is 1336373406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Addie Spier, M.D has received a total of $970.77 in payments from pharmaceutical and medical device companies, with $100.28 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($930.77).
As a Medicare-enrolled provider, Spier has provided services to 882 Medicare beneficiaries, totaling 1,449 services with total Medicare billing of $107,293. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease
- Location Columbia, SC
- Active Since 05/05/2009
- Last Updated 12/07/2023
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1336373406
Products in Payments
- AVYCAZ (Drug) $322.15
- TEFLARO (Drug) $114.21
- INTERSTIM (Device) $100.28
- CRESEMBA (Drug) $83.46
- Peripheral Orbital Atherectomy System (Device) $76.05
- LifeVest (Device) $53.72
- BIOFIRE RESPIRATORY PANEL 2.1 (Device) $40.00
- Arikayce (Drug) $24.77
- TRIUMEQ (Drug) $23.33
- VABOMERE (Drug) $19.75
- DIFICID (Drug) $18.03
- MINOCIN IV (Drug) $14.67
- Repatha (Biological) $14.55
- ORBACTIV (Drug) $10.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Columbia
Dr. Phillip Beck, M.d, M.D
Infectious Disease — Payments: $5,742
Infectious Disease $5,742
Dr. Robert Ross, M.d, M.D
Infectious Disease — Payments: $3,320
Infectious Disease $3,320
Dr. Eric Brener, M.d, M.D
Infectious Disease — Payments: $2,753
Infectious Disease $2,753
Harmeet Gill, Md, MD
Infectious Disease — Payments: $1,836
Infectious Disease $1,836
Pamela Bailey
Infectious Disease — Payments: $1,451
Infectious Disease $1,451
Amy Bowers, Do, DO
Infectious Disease — Payments: $1,227
Infectious Disease $1,227